Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Operable Breast Cancer”

199 trials

Showing 20 of 199 results

Early research (Phase 1)Study completedNCT00880464
What this trial is testing

Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 8
Testing effectiveness (Phase 2)Study completedNCT01669252
What this trial is testing

Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast Cancer

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 163
Testing effectiveness (Phase 2)Study completedNCT02488564
What this trial is testing

Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer

Who this might be right for
HER-2 Positive Breast Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 49
Not applicableUnknownNCT02797652
What this trial is testing

Clinical Application of CTDNA in Operable Breast Cancer Patients

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 60
Not applicableStudy completedNCT03860740
What this trial is testing

Effect of Physical Exercise on Tumor Proliferation of Luminal B Breast Cancer Patients

Who this might be right for
Breast CancerLuminal B
Spanish Breast Cancer Research Group 12
Testing effectiveness (Phase 2)Study completedNCT00405678
What this trial is testing

Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.

Who this might be right for
Breast Cancer
Duke University 23
Large-scale testing (Phase 3)Study completedNCT00312208
What this trial is testing

Docetaxel in Breast Cancer

Who this might be right for
Breast Cancer
Sanofi 3,299
Testing effectiveness (Phase 2)Study completedNCT00253500
What this trial is testing

Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 15
Large-scale testing (Phase 3)Study completedNCT02468739
What this trial is testing

Effect of GM1 in Prevention of Taxanes Induced Neurotoxicity in Operable Breast Cancer

Who this might be right for
Breast Cancer
Sun Yat-sen University 206
Testing effectiveness (Phase 2)Study completedNCT00256360
What this trial is testing

Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer

Who this might be right for
Breast Cancer
Universitaire Ziekenhuizen KU Leuven 117
Testing effectiveness (Phase 2)Study completedNCT00769470
What this trial is testing

Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Breast Cancer
Translational Oncology Research International 18
Testing effectiveness (Phase 2)Ended earlyNCT02720185
What this trial is testing

Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR

Who this might be right for
Breast NeoplasmsTriple Negative Breast Neoplasms
University of Wisconsin, Madison 5
Testing effectiveness (Phase 2)Study completedNCT00909506
What this trial is testing

Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer Patients

Who this might be right for
Breast Cancer
Seoul National University Hospital 105
Not applicableStudy completedNCT00068328
What this trial is testing

Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast CancerPsychosocial Effects of Cancer and Its Treatment
Alliance for Clinical Trials in Oncology 1,706
Testing effectiveness (Phase 2)Study completedNCT00239343
What this trial is testing

Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 160
Large-scale testing (Phase 3)Study completedNCT02187744
What this trial is testing

PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)

Who this might be right for
Early Breast Cancer
Pfizer 226
Not applicableStudy completedNCT00814034
What this trial is testing

Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal Therapy

Who this might be right for
Breast Cancer
Hellenic Breast Surgeons Society 306
Early research (Phase 1)Study completedNCT03916744
What this trial is testing

Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
Genentech, Inc. 75
Testing effectiveness (Phase 2)UnknownNCT03144947
What this trial is testing

Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer Patients

Who this might be right for
Cancer, Breast
Gruppo Oncologico Italiano di Ricerca Clinica 65
Large-scale testing (Phase 3)Study completedNCT05114720
What this trial is testing

Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer

Who this might be right for
Breast Cancer
Sun Yat-sen University 559
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation